Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASTEC: Allogeneic hMSCs in Mild Asthma
NCT03137199Phase 1Terminated
- Start
- Jun 2017
- Primary completion
- Mar 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label trial of MSV alogénicas in asthma (2 arms). Primary endpoint: Number of Participant with treatment emergent serious adverse events at Week 4. Started Jun 2017; status: terminated.
02
Drugs
MSV alogénicas
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03137199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03137199.